JP2004315386A5 - - Google Patents

Download PDF

Info

Publication number
JP2004315386A5
JP2004315386A5 JP2003108690A JP2003108690A JP2004315386A5 JP 2004315386 A5 JP2004315386 A5 JP 2004315386A5 JP 2003108690 A JP2003108690 A JP 2003108690A JP 2003108690 A JP2003108690 A JP 2003108690A JP 2004315386 A5 JP2004315386 A5 JP 2004315386A5
Authority
JP
Japan
Prior art keywords
derivative
acid
transglycosylation product
substituents
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003108690A
Other languages
English (en)
Other versions
JP4571783B2 (ja
JP2004315386A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003108690A priority Critical patent/JP4571783B2/ja
Priority claimed from JP2003108690A external-priority patent/JP4571783B2/ja
Publication of JP2004315386A publication Critical patent/JP2004315386A/ja
Publication of JP2004315386A5 publication Critical patent/JP2004315386A5/ja
Application granted granted Critical
Publication of JP4571783B2 publication Critical patent/JP4571783B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【請求項3】 請求項2における没食子の誘導体が、1乃至5個のガロイル基がグルコースに結合したものであることを特徴とする抗微生物剤。
【請求項5】 請求項1乃至4におけるヒドロキシ安息香酸の糖転移物及びヒドロキシケイ皮酸の糖転移物、又はそれらの誘導体が、炭素数1乃至12の炭化水素基を有する化合物であることを特徴とする抗微生物剤。
JP2003108690A 2003-04-14 2003-04-14 抗微生物剤 Expired - Fee Related JP4571783B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003108690A JP4571783B2 (ja) 2003-04-14 2003-04-14 抗微生物剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003108690A JP4571783B2 (ja) 2003-04-14 2003-04-14 抗微生物剤

Publications (3)

Publication Number Publication Date
JP2004315386A JP2004315386A (ja) 2004-11-11
JP2004315386A5 true JP2004315386A5 (ja) 2006-05-11
JP4571783B2 JP4571783B2 (ja) 2010-10-27

Family

ID=33470081

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003108690A Expired - Fee Related JP4571783B2 (ja) 2003-04-14 2003-04-14 抗微生物剤

Country Status (1)

Country Link
JP (1) JP4571783B2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5083541B2 (ja) * 2005-08-12 2012-11-28 ライオン株式会社 没食子酸誘導体及びそれを含有する外用剤組成物
CN101209254B (zh) * 2006-12-29 2011-04-20 江苏正大天晴药业股份有限公司 多羟基没食子酰基-β-D-葡萄糖衍生物的用途
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
GB0819958D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
ITTO20110428A1 (it) * 2011-05-13 2012-11-14 Rottapharm Spa Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
EP2844083B1 (en) 2012-04-23 2018-07-25 University Of Oslo Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
CN103044500B (zh) * 2012-12-14 2016-07-06 乐山师范学院 一种有机酸的制备及抗菌应用
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
JP6336424B2 (ja) * 2015-10-09 2018-06-06 日清食品ホールディングス株式会社 抗菌剤および海洋生物の腸炎ビブリオの感染による疾病を抑制する方法
JP7104032B2 (ja) 2016-11-02 2022-07-20 プロヴェクシス ナチュラル プロダクツ リミテッド 大気汚染の悪影響に対する水溶性トマト抽出物の保護
US20190076335A1 (en) * 2017-09-12 2019-03-14 IntraMont Technologies, Inc. Oral-surface administered preparation for the prevention of illnesses acquired via the oral cavity and the pharynx
CN108653338A (zh) * 2018-07-12 2018-10-16 石河子大学 没食子中抑制肠道致病菌的有效部位生产方法及用途
CN108904541A (zh) * 2018-07-12 2018-11-30 石河子大学 没食子中抑制牙周疾病致病菌有效部位的生产方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2997358B2 (ja) * 1992-01-30 2000-01-11 ポーラ化成工業株式会社 皮膚外用剤
JPH08217674A (ja) * 1995-02-16 1996-08-27 Noda Sangyo Kagaku Kenkyusho ヒスチジン脱炭酸酵素阻害剤
JP3571111B2 (ja) * 1995-05-23 2004-09-29 株式会社ポッカコーポレーション 抗微生物剤
KR20020089440A (ko) * 2000-04-11 2002-11-29 다카라 바이오 가부시키가이샤 치료제
WO2002022138A1 (en) * 2000-09-15 2002-03-21 Cubist Pharmaceuticals, Inc. Antibacterial agents and methods of identification

Similar Documents

Publication Publication Date Title
JP2004315386A5 (ja)
NL300933I2 (nl) Letermovir
WO2006117885A8 (ja) 皮膚外用剤
WO2007010281A3 (en) Use of thiazole derivatives and analogues in disorders caused by free fatty acids
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
HK1081945A1 (en) Process for the synthesis of 4,5-dimethoxy-1-(methylaminomethyl)-benzocy clobutane, and the use thereof
MXPA02012905A (es) Derivados de colquinol como agentes de dano vascular..
WO2005116002A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
JP2003520232A5 (ja)
WO2007009656A3 (de) Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
AU2005313582A8 (en) Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease
JP2008515980A5 (ja)
WO2006077025A3 (en) Morpholines as 5ht2c agonists
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
WO2006088814A3 (en) Dosage form and method for sustained release of a substituted pyrazine compound
JP2008513426A5 (ja)
WO2005112914A3 (en) Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
JP2008513427A5 (ja)
HUP0302025A2 (hu) Fungicid hatású vegyületkombinációk
WO2002028821A3 (de) Propionsäurederivate mit ppar-alpha aktivierenden eigenschaften.
WO2002009717A1 (fr) Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif
JP2006089487A5 (ja)